Evert Schimmelpennink is President and Chief Executive Officer of LENZ Therapeutics, Inc. (LENZ). The company reported total compensation of $7,036,009 for fiscal year 2025.
| Salary | $690,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $5,793,809 |
| Non-equity incentive plan | $538,200 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $14,000 |
| Total | $7,036,009 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure LENZ Therapeutics, Inc. filed April 28, 2026, accession 0001815776-26-000026.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Evert Schimmelpennink this page | President and Chief Executive Officer | $7,036,009 |
| Marc Odrich | Chief Medical Officer | $2,436,788 |
| Shawn Olsson | Chief Commercial Officer | $2,387,388 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full LENZ Therapeutics, Inc. compensation brief.
Evert Schimmelpennink's compensation sits inside LENZ Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.